Joined March 2019
25 Photos and videos
Eric Nesbit retweeted
Dear med students: If you're looking for that dream residency with the ideal blend of case volume and academic time for studying/research, a nurturing training environment with wonderfully kind faculty, and a workplace that looks more like a hotel than a hospital, check out mine!
1
16
36
Our article on the efficacy of RT for myeloid sarcoma including promising results with single-fraction RT is now available! Access at authors.elsevier.com/c/1dNY-…. Many thanks to coauthors @MichaelRooney67 @EricDonnellyMD @b_mittal0 @SeanSachdevMD #radonc #AMLsm #leusm @LurieCancer
1
6
Eric Nesbit retweeted
Replying to @NorthwesternMed
@NorthwesternMed #radonc is now accepting applications on @AAMCtoday VSLO! Institution: @NUFeinbergMed. Elective: RADIOL-4643. If interested in our department, please kindly DM me or rising chief resident @KRRogacki for info. We love #meded, and delicious deep dish awaits!

ALT chicago illinois GIF

1
4
19
Unnecessary Movie Critiques a la @neiltyson, #RadOnc Edition! Saw this pop up in the intro of Thunder Force, when cosmic radiation causes genetic mutations in a select few. So far so good, but… 1. Ionizing radiation doesn’t have different effects on “sociopath” vs normal brains
1
3
2. These look like CBV maps, which is fun! But what on earth is going on in the lateral ventricles of the normal brains? I look forward to a full correction to be broadcast during next weekend’s Academy Awards. #RuinAMovie #RadOnc
1
2
Duolingo getting a little too real #radonc #arro #abr
3
1
24
Eric Nesbit retweeted
We're excited to welcome Dr. Jason Efstathiou from MGH @harvardmed @DanaFarber as @LurieCancer grand rounds speaker tomorrow! He will also serve as visiting professor in #radonc. Medical students, please message chief residents: @AshackMd, @EricNesbitMD for link access.
1
7
35
Scientific Session GU 04 really valuable session! astro.6connex.com/event/virt… ASCENDE-RT update, FLAME trial both promising. Standouts are are the two that show that MFS is strong surrogate for OS (but bPFS isn't). Have to power trials for patient-centered outcomes #pcsm #ASTRO20

1
SH-04: Lung Cancer Intracranial management of SCLC continues to shift! Pattern of failure analysis from IMpower133 presented by @KHigginsMD demonstrates addition of atezolizumab delays time to intracranial progression in ES-SCLC #ASTRO20 #lcsm
1
3
10
Combine these results with no OS benefit with MRI surveillance vs PCI in the Takahashi study, and the evidence supporting use of upfront SRS for brain metastases from the FIRE-SCLC study… May further erode any potential survival benefit of routine PCI in ES-SCLC. #ASTRO20 #lcsm
1
2
3
Hopefully the MAVERICK trial will be the RCT to help answer these questions in the era of immunotherapy and MRI surveillance! #ASTRO20 #lcsm
3
5
Our collaboration with Sperduto et al. updating the GPA for patients with brain mets is now out in JCO! Hope that this work can help clarify prognosis in clinical practice and improve enrollment of patients with brain mets in clinical trials #btsm #radonc ascopubs.org/doi/full/10.120…
2
13
42
These are great points about the impact of staging in clinical trials. One other point I’ll add is upstaging! (1/6)
Staging matters Let's say a drug co has a drug that works in the metastatic setting and they run an adjuvant trial They have every incentive to do BAD staging No PET CTs No MRIs The worse they stage, the more likely they are to win Why? [thread]
2
4
Simultaneously, you've removed the worst disease from the localized category, so the new median patient in the localized subset will *also* do better! (5/6)
1
Taking this effect of upstaging into account is really important, especially in single-arm studies against a historical control - it may not be the new therapy that's improving median survival, it may just be the new staging! (6/6)